Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss during breast cancer treatment affects each woman differently, influenced by her environment and family.

Spironolactone is safe for breast cancer survivors with alopecia and does not increase cancer risk.

Long-term use of oral contraceptives, especially starting before age 20, may increase the risk of early-onset breast cancer.

A specific hair diffraction pattern may indicate breast cancer if tested with the correct method.

Most patients tolerated spironolactone for acne and hirsutism despite common side effects like menstrual changes and breast tenderness.

High doses of norethindrone acetate in rats caused various organ changes but didn't significantly increase tumor rates.

Breast implants are linked to autoimmune symptoms, with over half of patients feeling better after removal, but the exact cause is unclear and may involve bacterial biofilm.

Breast cancer skin metastases are rare, look different, and can be confused with other skin issues, so a biopsy is needed for accurate diagnosis.

Breast cancer survivors may have a higher risk of falls, tamoxifen could prevent breast cancer and deaths, new guidelines urge caution with prostate cancer therapy, and early balding in men may indicate a higher prostate cancer risk.

Preventive measures and effective management are crucial for reducing skin side effects in cancer treatment.

KLF4 is important for maintaining stem cells and has potential in cancer treatment and wound healing.

X-ray diffraction of hair might help detect breast cancer non-invasively.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

Finasteride may help some women with hair loss, but better options exist.

Alopecia areata patients have varied cancer risks, with some cancers being lower and others higher.

Spironolactone reduces hair growth in women with unexplained excessive hairiness.

YH0618 granules may help prevent hair loss in breast cancer patients undergoing chemotherapy.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

Using 5-alpha reductase inhibitors may lower the risk of breast cancer in females.

Hirsutism is common body hair growth due to genetics and hormones, and while not a disease, it can be distressing; virilisation includes hirsutism with other male traits and needs medical attention.

SACUMAN, a rare condition causing hair loss without clear signs, is often misdiagnosed and needs scalp biopsies for accurate detection.

Permanent hair loss from chemotherapy significantly impacts patients' mental health and social life, highlighting the need for better patient education and support.

Cyproterone acetate is a safe treatment that causes mild feminizing effects and is more effective with added estrogens.

A 24-month-old Nigerian girl developed early puberty with no family history, needing treatment her family couldn't afford.

Scalp cooling effectively prevents severe hair loss in breast cancer patients treated with docetaxel and is safe.

CDK4/6 inhibitors may cause hair loss in breast cancer patients.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Kalya Research is an AI tool that effectively finds and analyzes alternative medicine literature, saving researchers time.

Early sexual development in children, especially girls, can be treated with hormone therapy to improve adult height and requires support for the child and family.